Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Liushun Biotechnology is a life sciences company headquartered in Guangzhou, China, specializing in the development and production of high-quality biological reagents and providing contract research services. The company's core product line includes recombinant proteins, monoclonal and polyclonal antibodies, and essential raw materials for diagnostic kits. Liushun Biotechnology also offers a suite of CRO services, including custom protein expression and purification, antibody development, and stable cell line construction to support pharmaceutical R&D. By leveraging its expertise in protein engineering and immunology, the company serves as a key partner for academic institutions and biotech firms worldwide. The company is recognized as a High-Tech Enterprise and operates out of the Guangzhou Science City biotech cluster.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Liushun Biotechnology.